Clinical Trial Update: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating CAR-pNK cell immunotherapy for CD7-positive leukemias and lymphomas. The available snippet does not provide trial out…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Angioimmunoblastic T-cell Lymphoma
• Extranodal Nk T-cell Lymphoma Nasal Type
• Hepatosplenic T-cell Lymphoma
• Peripheral T-cell Lymphoma Nos
• Precursor T-cell Lymphoblastic Leukemia Lymphoma
• T-cell Large Granular Lymphocytic Leukemia
• T-cell Prolymphocytic Leukemia

Drugs mentioned

• CAR-pNK Cell Immunotherapy

Snippet

Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Conditions: Acute Myeloid Leukemia, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN